Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication ‐ a prospective study for up to 10 years
Alimentary Pharmacology & Therapeutics2017Vol. 47(3), pp. 380–390
Citations Over TimeTop 1% of 2017 papers
Young‐Jae Hwang, Nayoung Kim, Hye Seung Lee, J. B. Lee, Yoon Jin Choi, Hyuk Yoon, Cheol Min Shin, Y. S. Park, Daniel J. Lee
Abstract
H. pylori eradication may be a preventative strategy for intestinal-type gastric cancer by regression of atrophic gastritis and intestinal metaplasia.
Related Papers
- → Most Gastric Cancer Occurs on the Distal Side of the Endoscopic Atrophic Border(1999)34 cited
- The effect of helicobacter pylori in intestinal metaplasia and atrophic gastritis(2009)
- Clinical Study on Treating 78 cases of Precancerous Chronic Atrophic Gastritis According to Syndrome Differentiation(2005)
- Influence of Shanwei Prescription on P16 Protein in Atrophic Gastritis Patients in Precancer period with Deficiency of Both Qi and Yin(2006)
- [Alterations and clinical implications of interleukin 23 and pepsinogen 1 in the sera and tissues of patients with gastric diseases].(2016)